Isidoro Wiener
Surgery · Houston, TXNPI 1457353294
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $641 and has fallen 67.4% since, to $209 in 2025. That places this record below the midpoint for surgery clinicians in TX, where the typical reported total is $2,700.
Across 23 payments — averaging $85.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$468
- Abbott$403
- Regeneron Healthcare Solutions, Inc.$234
- Nevro Corp.$132
- Sanofi$125
- Baxter Healthcare$117
- plus $491 from 5 others
Across 79 payments — averaging $10,729 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Grifols Biologicals LLC$270K
- Janssen Research & Development, LLC$188K
- Takeda Pharmaceuticals U.S.A., Inc.$187K
- Hikma Pharmaceuticals USA$176K
- Heron Therapeutics, Inc.$26K
- Grifols Therapeutics LLC$574
What the payments were for
- Food & beverage$1,970100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 8 | $468 |
| Abbott | 4 | $403 |
| Regeneron Healthcare Solutions, Inc. | 2 | $234 |
| Nevro Corp. | 2 | $132 |
| Sanofi | 1 | $125 |
| Baxter Healthcare | 1 | $117 |
| KCI USA, Inc. | 1 | $115 |
| GSK | 1 | $102 |
| Novo Nordisk | 1 | $96 |
| Pharming Healthcare, Inc. | 1 | $94 |
| Biogen | 1 | $84 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$359
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$311
- PHASIX$284
- Renal - PD$117
- VAC VERAFLO$115
- PREVENA$115
- BEXSERO$102
How this compares
$1,970 in reported general payments places this provider in the 40th percentile of 1,830 surgery providers in Texas.
Other surgery in Houston
- James SuliburkHouston$161K
- Funda MericHouston$141K
- Jonathan StahlHouston$105K
- Richard KnightHouston$103K
- Tanyaradzwa KajeseHouston$92K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.